Eli Lilly and Company

LLY

1255.40 (0.78%) 9.75

Health Care

Pharmaceuticals

Eli Lilly and Company discovers develops manufactures and markets human pharmaceutical products in the United States Europe China Japan and internationally. The company offers cardiometabolic health products including Basaglar Humalog Humalog Mix 75/25 Humalog U-100 Humalog U-200 Humalog Mix 50/50 insulin lispro insulin lispro protamine insulin lispro mix 75/25 Humulin Humulin 70/30 Humulin N Humulin R Humulin U-500 for diabetes; Jardiance Mounjaro and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products such as Cyramza for the second-line treatment of gastric cancer or gastro-esophageal junction adenocarcinoma; Erbitux for colorectal cancers and head and neck cancers; Inluriyo for breast cancer; Jaypirca for chronic lymphocytic leukemia or small lymphocytic lymphoma; Retevmo for the treatment of metastatic NSCLC; TYVYT for classic hodgkin’s lymphoma; and Verzenio for breast cancer. In addition the company offers immunology products which include Ebglyss for severe atopic dermatitis; Olumiant for rheumatoid arthritis atopic dermatitis severe alopecia areata and COVID-19; Omvoh for ulcerative colitis; and Taltz for plaque psoriasis psoriatic arthritis ankylosing spondylitis and non-radiographic axial spondylarthritis. Further it provides Emgality for migraine prevention and episodic cluster headache as well as Kisubla for symptomatic Alzheimer’s disease. The company has collaborations with Boehringer Ingelheim Pharmaceuticals Inc. for the Jardiance product family; and F. Hoffmann-La Roche Ltd and Genentech Inc. for lebrikizumab as well as license agreements with Almirall S.A. for Ebglyss; and Chugai Pharmaceutical Co. Ltd for orforglipron; strategic collaboration with Ascidian Therapeutics for development of therapies for undisclosed monogenic kidney diseases; and BioArctic AB (publ) for new treatment. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis Indiana.

Quality Checklist 6/8

5Y Shares Out Change < 0%

ROIC > 10%

Current Ratio > 1

Net Margin > 10%

Past Net Income CAGR > 0%

Est. EPS Growth > 5%

Debt/Equity < 1

Quick Ratio > 1

0.0%of Portfolio

My holdings

Day change:

Total change:

Cost basis:

Market cap: $1.12(T)

EV: $1.16(T)

Total Equity: $33.88(B)

Earnings date: Oct-29-2026

P/E: 42.06

Forward P/E: 34.47

P/FCF: 61.54

P/S: 14.10

P/B: 33.04

EPS: $29.9

EPS (fwd): $36.4

FCF/share: $20.4

Revenue/share: $89.0

Book value/share: $38.0

ROIC: 32.9%

ROA: 19.3%

ROE: 96.8%

Debt/Equity: 1.62

Current Ratio: 1.40

Gross margin: 83.4%

Operating margin: 45.1%

Net margin: 33.5%

Dividend/share: $6.5

Div. yield: 0.51%

All Valuation Overview Growth Financials & KPIs Competitors & Peer Comparison Ownership Tools

LLY Valuation & Price Targets

Current Price

$1255

Favorite Valuation Methods

PEvaluation

N/A

Analyst targets

N/A

DCF (2-stage)

N/A

More Valuation Methods

DCF (simple)

N/A

DCF (exit mult.)

N/A

DDM

N/A

EPS growth

N/A

Revenue growth

N/A

Peter Lynch FV

N/A

Graham No.

N/A

PEvaluation

21% overvalued

Low

$745

Mid

$993

High

$1241

Current price

$1255

Fair P/E

Margin of safety

EPS

Market Model

Economic moat: Very wide

EPS Estimates

	Low	Avg	High	#
FY+1	32.5	36.4	38.6	25
FY+2	40.4	46.6	52.3	24
FY+3	44.8	53.6	62.8	19
FY+4	51.5	59.2	69.3	12
FY+5	59.5	65.4	74.5	12

Analyst Price Targets

7% undervalued

Low

$850

Mid

$1344

High

$1600

Current price

$1255

Analyst Recommendations

Strong Buy5

Buy17

Hold4

Sell1

Strong Sell1

2-stage DCF

First Stage Duration: 5 Years

Starting Free Cash Flow
First Stage Growth Rate
LowMidHigh

Terminal Growth Rate
LowMidHigh

Discount Rate

Discounted Cash Flow

Forecast years: 5 Years

Terminal Growth Rate
LowMidHigh

Discount Rate

Free cash flow estimates:

Y+1 est.

Y+2 est.

0.00%

Y+3 est.

0.00%

Y+4 est.

0.00%

Y+5 est.

0.00%

Discounted Cash Flow (exit mult.)

Forecast years: 5 Years

Exit FCF Multiple
LowMidHigh

Discount Rate

Free cash flow estimates:

Y+1 est.

Y+2 est.

0.00%

Y+3 est.

0.00%

Y+4 est.

0.00%

Y+5 est.

0.00%

Dividend Discount Model

Annual Dividend
First Stage Length (Years): 0 Years

First Stage Growth Rate
Final Growth Rate
Discount Rate

EPS Growth

Forecast years: 5 Years

Starting EPS
EPS Growth Rate
LowMidHigh

Final P/E
LowMidHigh

Discount Rate

Revenue Growth Valuation

Forecast Years: 10 Years

Base Revenue
Revenue Growth Rate
LowMidHigh

Final Net Margin
LowMidHigh

Final P/E Ratio
LowMidHigh

Discount Rate

Peter Lynch Fair Value

Earnings Per Share
Growth Rate

Graham Formula

Earnings Per Share
EPS Growth (7-10 years)
Government Bond Rate

TTM Financials

Income (TTM)

Revenue$79.67(B)

Gross profit$66.44(B)

EBITDA$41.71(B)

Net income$26.71(B)

Gross margin83.4%

Operating margin45.1%

Net margin33.5%

Shares outstanding891.36(M)

Balance sheet

Total assets$142.28(B)

Current assets$64.67(B)

Total liabilities$108.40(B)

Current liabilities$47.74(B)

Cash & Short-term inv.$8.95(B)

Long-term debt$47.86(B)

Total intangibles$26.96(B)

PP&E$29.29(B)

Cash flow (TTM)

FCF$18.19(B)

CapEx$-9.89(B)

Dividends paid$-5.79(B)

Stock issued$0

Stock repurchased$-6.17(B)

Stock-based comp.$649.00(M)

Debt issued$20.93(B)

Debt repaid$-5.71(B)

Per share data (TTM)

Summary

Growth Estimates

Revenue

CAGR: 10.8%

FY+1$87.49(B)

FY+2(+15.1%)$100.68(B)

FY+3(+11.6%)$112.34(B)

FY+4(+9.4%)$122.92(B)

FY+5(+7.5%)$132.08(B)

Net Income

CAGR: 15.3%

FY+1$32.63(B)

FY+2(+27.5%)$41.61(B)

FY+3(+14.0%)$47.44(B)

FY+4(+10.5%)$52.42(B)

FY+5(+10.2%)$57.77(B)

EPS

CAGR: 15.8%

FY+1$36.42

FY+2(+27.8%)$46.56

FY+3(+15.2%)$53.63

FY+4(+10.3%)$59.17

FY+5(+10.5%)$65.39

FCF per share

CAGR: 23.9%

FY+1$23.94

FY+2(+44.9%)$34.68

FY+3(+20.7%)$41.85

FY+4(+19.0%)$49.82

FY+5(+13.0%)$56.32

Historical Financials

Showing limited histrical data.

Upgrade to access 10+ years of financials!

TTM (Y)TTM (Q)FYFQ

Income(show more...)

Revenue Operating Income Net IncomeCOGSGross ProfitTotal OpEx.R&DSG&AInterest ExpenseInterest IncomeOther Non-operating IncomePre-tax incomeIncome tax

Cash flow(show more...)

Stock-based Comp. FCFCFONet IncomeD&AChange in Working CapitalCFFStock IssuedStock RepurchasedDebt IssuedDebt RepaidDividend PaidCFIAcquisitionsDivestituresCapital Expenditures

Balance sheet(show more...)

Total Assets Total LiabilitiesCurrent assetsCash and EquivalentsShort-term investmentsInventoriesReceivablesNon-current assetsNet PP&EIntangible AssetsGoodwillCurrent liabilitiesShort-Term DebtAccounts payableNon-current liabilitiesLong-Term DebtTotal Equity

Per share data(show more...)

EPS (Basic) FCF/Share Dividend/ShareEPS (Diluted)Book value/ShareCash & ST inv./ShareDebt/Share

Ratios(show more...)

P/E P/S EV/EarningsP/FCFP/BEV/FCFDebt/EquityPayout ratio

Margins(show more...)

Net Income Margin Operating Margin Gross MarginEBITDA MarginFCF Margin

Returns(show more...)

ROIC ROAROCEROE

Shares outstanding(show more...)

Shares (Basic)Shares (Diluted)

Market Cap.(show more...)

Market Cap.

KPIs

Operating Expense Breakdown(show more...)

Research and Development Impairment, Restructuring, and Other Marketing, Selling, and Administrative Acquired In-Process Research and Development

Revenue By Geography(show more...)

Rest of World United States Europe China Japan

Revenue By Segment(show more...)

Neuroscience Immunology Cardiovascular Oncology Animal Health Cardiometabolic Other

LLY vs Peers

Similar Companies

Ownership

Major holders

*Excludes indirect insider ownership

Insiders: 0.16%
Institutions: 85.44%
Other: 14.41%

Institutional ownership

Trading Summary

In the past year, insiders have bought $1.64(M) worth of the company's stock, and sold $3.64(B).

Congress members have bought between $37009 - $205000 worth of the company's stock, and sold between $22008 - $155000.

Insider transactions

$0.002026-09$0.00

$5.95(M)2026-08$0.00

$0.002026-07$0.00

$2.88(M)2026-06$0.00

$15.75(M)2026-05$0.00

$0.002026-04$0.00

$0.002026-03$0.00

$0.002026-02$0.00

$323.89(M)2026-01$0.00

$7.01(M)2025-12$0.00

$2.04(B)2025-11$0.00

$1.06(B)2025-10$0.00

$186.38(M)2025-09$0.00

	Date	Shares	Total ($)	Price ($)	Name	Title
Sell	2026-08-07	5,000	5,950,000	1190.0	HAKIM ANAT	General Counsel
Grant	2026-07-20	4	4,958	1239.5	SULZBERGER GABRIELLE	Director
Grant	2026-07-20	10	12,417	1241.7	ALVAREZ RALPH	Director
Grant	2026-07-20	8	9,917	1239.6	FYRWALD J. ERIK	Director
Grant	2026-07-20	13	15,917	1224.4	LUCIANO JUAN R	Director
Grant	2026-06-15	4	4,958	1239.5	SULZBERGER GABRIELLE	Director
Grant	2026-06-15	10	12,417	1241.7	ALVAREZ RALPH	Director
Grant	2026-06-15	8	9,917	1239.6	FYRWALD J. ERIK	Director
Grant	2026-06-15	14	15,917	1136.9	LUCIANO JUAN R	Director
Sell	2026-06-10	2,500	2,876,925	1150.8	YUFFA ILYA	Officer
Grant	2026-05-18	5	4,958	991.6	SULZBERGER GABRIELLE	Director
Grant	2026-05-18	12	12,416	1034.7	ALVAREZ RALPH	Director
Grant	2026-05-18	10	9,916	991.6	FYRWALD J. ERIK	Director
Grant	2026-05-18	16	15,917	994.8	LUCIANO JUAN R	Director
Sell	2026-05-06	15,828	15,754,537	995.4	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Grant	2026-04-20	5	4,958	991.6	SULZBERGER GABRIELLE	Director
Grant	2026-04-20	13	12,417	955.2	ALVAREZ RALPH	Director
Grant	2026-04-20	10	9,917	991.7	FYRWALD J. ERIK	Director
Grant	2026-04-20	17	15,917	936.3	LUCIANO JUAN R	Director
Grant	2026-03-16	5	4,958	991.6	SULZBERGER GABRIELLE	Director
Grant	2026-03-16	12	12,416	1034.7	ALVAREZ RALPH	Director
Grant	2026-03-16	10	9,917	991.7	FYRWALD J. ERIK	Director
Grant	2026-03-16	16	15,917	994.8	LUCIANO JUAN R	Director
Grant	2026-02-19	481	0	0.0	DOZIER ERIC	Officer
Grant	2026-02-17	4	4,959	1239.8	SULZBERGER GABRIELLE	Director
Grant	2026-02-17	11	12,417	1128.8	ALVAREZ RALPH	Director
Grant	2026-02-17	9	9,917	1101.9	FYRWALD J. ERIK	Director
Grant	2026-02-17	15	15,917	1061.1	LUCIANO JUAN R	Director
Grant	2026-02-09	15,547	16,242,385	1044.7	SKOVRONSKY DANIEL	Officer
Grant	2026-02-09	1,365	1,426,466	1045.0	MONTARCE LUCAS E	Chief Financial Officer
Grant	2026-02-09	4,818	5,033,274	1044.7	JONSSON PATRIK	Officer
Grant	2026-02-09	583	609,862	1046.1	ZAKROWSKI DONALD A	Officer
Grant	2026-02-09	38,913	40,651,854	1044.7	RICKS DAVID A	Chief Executive Officer
Grant	2026-02-09	3,512	3,669,188	1044.8	DOZIER ERIC	Officer
Grant	2026-02-09	659	688,730	1045.1	CUSTER KENNETH L	Officer
Grant	2026-02-09	1,196	1,249,747	1044.9	BROWN ADRIENNE S	Officer
Grant	2026-02-09	4,162	4,348,443	1044.8	YUFFA ILYA	Officer
Grant	2026-02-09	4,383	4,579,555	1044.8	HERNANDEZ EDGARDO	Officer
Grant	2026-02-09	4,432	4,630,312	1044.7	RAU DIOGO	Chief Technology Officer
Grant	2026-02-09	4,599	4,804,609	1044.7	RAU DIOGO	Officer
Grant	2026-02-09	4,865	5,083,247	1044.9	VAN NAARDEN JACOB S.	Officer
Grant	2026-02-09	8,277	8,647,694	1044.8	HAKIM ANAT	General Counsel
Grant	2026-01-20	4	4,959	1239.8	SULZBERGER GABRIELLE	Director
Grant	2026-01-20	11	12,416	1128.7	ALVAREZ RALPH	Director
Grant	2026-01-20	9	9,916	1101.8	FYRWALD J. ERIK	Director
Grant	2026-01-20	15	15,917	1061.1	LUCIANO JUAN R	Director
Sell	2026-01-07	292,148	322,380,730	1103.5	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2026-01-05	1,390	1,508,165	1085.0	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-12-29	3,593	3,898,531	1085.0	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-12-24	2,629	2,852,920	1085.2	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-12-23	240	260,409	1085.0	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Grant	2025-12-15	4	4,958	1239.5	SULZBERGER GABRIELLE	Director
Grant	2025-12-15	11	11,750	1068.2	ALVAREZ RALPH	Director
Grant	2025-12-15	9	9,917	1101.9	HEDLEY MARY LYNNE	Director
Grant	2025-12-15	9	9,917	1101.9	FYRWALD J. ERIK	Director
Grant	2025-12-15	13	14,833	1141.0	LUCIANO JUAN R	Director
Sell	2025-11-25	147,061	161,082,640	1095.3	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-11-25	15,632	17,340,625	1109.3	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-11-24	142,307	152,058,091	1068.5	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-11-21	105,326	111,504,098	1058.7	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-11-20	37,148	39,067,117	1051.7	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-11-19	167,526	176,098,702	1051.2	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-11-18	60,213	62,306,969	1034.8	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-11-17	9,886	10,189,269	1030.7	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Grant	2025-11-17	215	220,000	1023.3	KAELIN WILLIAM G JR	Director
Grant	2025-11-17	215	220,000	1023.3	BAICKER KATHERINE	Director
Grant	2025-11-17	220	224,958	1022.5	SULZBERGER GABRIELLE	Director
Grant	2025-11-17	215	220,000	1023.3	JACKSON JAMERE	Director
Grant	2025-11-17	215	220,000	1023.3	JOHNSON KIMBERLY H	Director
Grant	2025-11-17	226	231,749	1025.4	ALVAREZ RALPH	Director
Grant	2025-11-17	225	229,916	1021.8	HEDLEY MARY LYNNE	Director
Grant	2025-11-17	233	238,333	1022.9	MOELLER JON R	Director
Grant	2025-11-17	225	229,916	1021.8	FYRWALD J. ERIK	Director
Grant	2025-11-17	229	234,833	1025.5	LUCIANO JUAN R	Director
Sell	2025-11-14	178,295	183,799,044	1030.9	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-11-13	1,000	1,010,500	1010.5	ZAKROWSKI DONALD A	Officer
Sell	2025-11-13	46,606	48,016,098	1030.3	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-11-12	305,000	308,411,204	1011.2	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-11-11	283,131	279,347,680	986.6	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-11-10	16,869	16,405,396	972.5	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Grant	2025-11-10	179	0	0.0	SKOVRONSKY DANIEL	Officer
Grant	2025-11-10	24,750	0	0.0	RICKS DAVID A	Chief Executive Officer
Sell	2025-11-05	179,042	167,092,104	933.3	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-11-05	40,432	38,473,442	951.6	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-11-04	526	479,038	910.7	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-11-03	300,000	266,648,921	888.8	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-10-31	301,342	260,165,031	863.4	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Grant	2025-10-20	6	4,958	826.3	SULZBERGER GABRIELLE	Director
Grant	2025-10-20	14	11,750	839.3	ALVAREZ RALPH	Director
Grant	2025-10-20	12	9,917	826.4	FYRWALD J. ERIK	Director
Grant	2025-10-20	18	14,833	824.1	LUCIANO JUAN R	Director
Sell	2025-10-10	3,658	3,157,722	863.2	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-10-09	10,602	9,038,055	852.5	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-10-08	101,420	86,234,874	850.3	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-10-07	26,795	22,722,401	848.0	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-10-06	161,183	137,041,657	850.2	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-10-03	192,404	161,220,401	837.9	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-10-02	112,596	92,503,361	821.6	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-10-01	135,193	107,363,016	794.1	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-10-01	215,822	177,290,448	821.5	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-09-30	113,694	86,793,274	763.4	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-09-19	23,665	18,058,643	763.1	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Sell	2025-09-18	106,626	81,531,959	764.7	LILLY ENDOWMENT, INC.	Beneficial Owner of more than 10% of a Class of Security
Grant	2025-09-15	6	4,958	826.3	SULZBERGER GABRIELLE	Director
Grant	2025-09-15	15	11,750	783.3	ALVAREZ RALPH	Director
Grant	2025-09-15	13	9,917	762.8	HEDLEY MARY LYNNE	Director
Grant	2025-09-15	13	9,917	762.8	FYRWALD J. ERIK	Director
Grant	2025-09-15	19	14,834	780.7	LUCIANO JUAN R	Director
Grant	2025-09-05	17	0	0.0	HERNANDEZ EDGARDO	Officer
Sell	2025-08-28	1,000	734,930	734.9	ZAKROWSKI DONALD A	Officer
Grant	2025-08-18	7	4,958	708.3	SULZBERGER GABRIELLE	Director
Grant	2025-08-18	16	11,750	734.4	ALVAREZ RALPH	Director
Grant	2025-08-18	14	9,916	708.3	HEDLEY MARY LYNNE	Director
Grant	2025-08-18	14	9,916	708.3	FYRWALD J. ERIK	Director
Grant	2025-08-18	21	14,834	706.4	LUCIANO JUAN R	Director
Buy	2025-08-15	715	494,627	691.8	MONTARCE LUCAS E	Chief Financial Officer
Buy	2025-08-13	1,000	647,360	647.4	VAN NAARDEN JACOB S.	Officer
Buy	2025-08-13	758	500,473	660.3	ALVAREZ RALPH	Director

Congressional trading

$0.002026-09$0.00

$0.002026-08$0.00

$0.002026-07$0.00

$0.002026-06$0.00

$0.002026-05$0.00

$0.002026-04$0.00

$0.002026-03$0.00

$0.002026-02$0.00

$80012026-01$8001

$160012025-12$40501

$485022025-11$8001

$0.002025-10$8001

$80012025-09$0.00

	Date	Politician	Party	Chamber	Amount ($)
Buy	2026-01-23	Ro Khanna	D	House	$1,001 - $15,000
Sell	2026-01-16	David J. Taylor	R	House	$1,001 - $15,000
Buy	2025-12-29	Angus S. King, Jr.	I	Senate	$1,001 - $15,000
Buy	2025-12-29	Markwayne Mullin	R	Senate	$15,001 - $50,000
Sell	2025-12-18	Julie Johnson	D	House	$1,001 - $15,000
Sell	2025-12-10	David J. Taylor	R	House	$1,001 - $15,000
Sell	2025-11-21	John Boozman	R	Senate	$1,001 - $15,000
Buy	2025-11-18	Gilbert Ray Cisneros, Jr.	D	House	$1,001 - $15,000
Sell	2025-11-13	Julie Johnson	D	House	$1,001 - $15,000
Sell	2025-11-07	Ro Khanna	D	House	$15,001 - $50,000
Buy	2025-10-24	Shelley Moore Capito	R	Senate	$1,001 - $15,000
Sell	2025-09-23	Val T. Hoyle	D	House	$1,001 - $15,000
Buy	2025-08-22	John Boozman	R	Senate	$1,001 - $15,000
Buy	2025-08-14	David J. Taylor	R	House	$15,001 - $50,000
Buy	2025-08-14	David J. Taylor	R	House	$1,001 - $15,000
Sell	2025-08-14	Julie Johnson	D	House	$1,001 - $15,000
Buy	2025-08-11	John Boozman	R	Senate	$1,001 - $15,000

Tools

Dividend Income

Investment Amount
Dividend Yield

What is the Dividend Income Calculator?

The Dividend Income Calculator helps you estimate the yearly, quarterly, monthly, and daily income of your investments.

How to Use This Calculator?

Enter the dividend yield and the invested amount. Optionally, preload stock data to automatically fetch the dividend yield.

Required Investment

Dividend Yield
Desired Yearly Payout
Desired Quarterly Payout
Desired Monthly Payout

What is the Required Investment Calculator?

The Required Investment Calculator helps you determine the amount of money you need to invest in a stock to achieve a desired dividend.

How to Use This Calculator?

Enter the dividend yield and your desired dividend income. Optionally, preload stock data to automatically fetch the dividend yield.

Future Dividend Yield

Base Dividend
Current Price
Number of Years
Dividend Growth Rate

What is the Future Yield Calculator?

The Future Yield Calculator helps you estimate the future dividend yield of a stock based on its current dividend, price, and expected dividend growth rate.

How to Use This Calculator?

Enter the base dividend, current price, number of years, and dividend growth rate. Optionally, preload stock data to automatically fetch the dividend and price. The calculator will display the current yield and the projected future yield.

Future Dividend Income

Base Dividend
Number of Years
Dividend Growth Rate

What is the Future Dividend Income Calculator?

The Future Dividend Income Calculator helps you estimate the future dividend income from your investments based on the current dividend yield and expected growth rate.

How to Use This Calculator?

Enter the current dividend yield, expected growth rate, and investment duration. Optionally, preload stock data to automatically fetch the dividend yield.

About

Terms & privacy

Price charts & news courtesy of TradingView

Blog

Contact